Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Healthtrust
Medtronic
Express Scripts
Moodys
Cerilliant
Johnson and Johnson
Dow

Generated: May 20, 2018

DrugPatentWatch Database Preview

MELFIAT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Melfiat, and when can generic versions of Melfiat launch?

Melfiat is a drug marketed by Numark and is included in two NDAs.

The generic ingredient in MELFIAT is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for MELFIAT
US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
DailyMed Link:MELFIAT at DailyMed
Drug patent expirations by year for MELFIAT

US Patents and Regulatory Information for MELFIAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Numark MELFIAT phendimetrazine tartrate TABLET;ORAL 083790-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Numark MELFIAT-105 phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 087487-001 Oct 13, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Chubb
Deloitte
Moodys
UBS
Colorcon
Federal Trade Commission
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.